Advertisement

Representations of Pre-exposure Prophylaxis, Informal Antiretroviral Medication Use for HIV Prevention, and Diversion on Geosocial Networking Apps among Men Who Have Sex with Men

  • Mance E. Buttram
  • Steven P. Kurtz
Original Paper

Abstract

The use of geosocial networking applications (e.g., Grindr) among men who have sex with men (MSM) is common. Yet scant research has examined how antiretroviral medications (ARVs)—including informal use—diversion and pre-exposure prophylaxis (PrEP) are presented inside of the applications. The present study examines this phenomenon. Data are drawn from a qualitative study (N = 39) of the scope and magnitude of the informal market of ARV use for HIV prevention among MSM. Twenty-five participants reported seeing references to ARVs inside the applications. Men described geosocial networking application users’ presentations of ARVs as being related to: PrEP use among HIV-negative MSM, the sale and/or use of illicit drugs (e.g., methamphetamine), informal trade/sale for HIV-prevention, and PrEP use among HIV-positive men. Findings suggest continued desire for and acceptability of PrEP as HIV prevention tool and that geosocial networking apps are being used to facilitate the exchange and informal use of ARVs for HIV-prevention. Geosocial networking applications represent a promising and important platform to educate MSM about safe and effective use of PrEP and the risks related to diversion and informal ARV use.

Keywords

Preexposure prophylaxis (PrEP) Geosocial networking apps Men who have sex with men (MSM) Antriretroviral medication Diversion 

Notes

Funding

This project was funded through a Nova Southeastern University President’s Faculty Research and Development Grant, Award No. 335380.

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflicts of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the university’s institutional review board and with the 1964 Helsinki declaration and its later amendments.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Young SD, Szekeres G, Coates T. The relationship between online social networking and sexual risk behaviors among men who have sex with men (MSM). PLoS ONE. 2013;8(5):e62271.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Grosskopf NA, Le Vasseur MT, Glaser DB. Use of the Internet and mobile-based “apps” for sex-seeking among men who have sex with men in New York City. Am J Mens Health. 2014;8(6):510–20.CrossRefPubMedGoogle Scholar
  3. 3.
    Rice E, Holloway I, Winetrobe H, et al. Sex risk among young men who have sex. J AIDS Clin Res. 2012;S4:005.Google Scholar
  4. 4.
    Landovitz RJ, Tseng C-H, Weissman M, et al. Epidemiology, sexual risk behavior, and HIV prevention practices of men who have sex with men using Grindr in Los Angeles, California. J Urban Health. 2013;90(4):729–39.CrossRefPubMedGoogle Scholar
  5. 5.
    Holloway IW, Rice E, Gibbs J, et al. Acceptability of smartphone application-based HIV prevention among young men who have sex with men. AIDS Behav. 2014;18(2):285–96.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Goedel WC, Halkitis PN, Greene RE, et al. HIV risk behaviours, perceptions, and testing and preexposure prophylaxis (PrEP) awareness/use in Grindr-using men who have sex with men in Atlanta, Georgia. J Assoc Nurses AIDS Care. 2016;27(2):133–42.CrossRefPubMedGoogle Scholar
  7. 7.
    Winetrobe H, Rice E, Bauermeister J, et al. Associations of unprotected anal intercourse with Grindr-met partners among Grindr-using men who Have sex with men in Los Angeles. AIDS Care. 2014;26(10):1303–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Eaton LA, Maksut JL, Gamarel KE, Siembida EJ, Driffin DD. Online sex partner meeting venues as a risk factor for testing HIV positive among a community-based sample of Black men who have sex with men. Sex Transm Dis. 2016;43(6):360–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Holloway IW, Dougherty R, Gidner J, et al. PrEP uptake, adherence, and discontinuation among California YMSM using geosocial networking applications. J Acquir Immune Defic Syndr. 2017;74(1):15–20.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Goedel WC, Halkitis PN, Greene RE, Duncan DT. Correlates of awareness of nd willingness to use pre-exposure prophylaxis (PrEP) in gay, bisexual, and other men who have sex with men who use geosocial-networking smartphone applications in New York City. AIDS Behav. 2016;20(7):1435–42.CrossRefPubMedGoogle Scholar
  12. 12.
    Rosengren AL, Huang E, Daniels J, et al. Feasibility of using Grindr to distribute HIV self-test kits to men who have sex with men in Los Angeles, California. Sex Health. 2016;13(4):389–92.CrossRefGoogle Scholar
  13. 13.
    Czarny HN, Broaddus MR. Acceptability of HIV prevention information delivered through established geosocial networking mobile applications to men who have sex with men. AIDS Behav. 2017;21(11):3122–318.CrossRefPubMedGoogle Scholar
  14. 14.
    Inciardi JA, Surratt HL, Kurtz SP, Burke JJ. The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst Use Misuse. 2006;41(2):255–64.CrossRefPubMedGoogle Scholar
  15. 15.
    Kurtz SP, Buttram ME, Surratt HL. Vulnerable infected populations and street markets for ARVs: potential implications for PrEP rollout in the US. AIDS Care. 2014;26(4):411–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Liu AY, Kittredge PV, Vittinghoff E, Raymond HF, Ahrens K, Matheson T, et al. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008;47(2):241–7.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Mansergh G, Koblin BA, Colfax GN, McKirnan DJ, Flores SA, Hudson SM. Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among US men who have sex with men. J Acquir Immune Defic Syndr. 2010;55(2):e14–6.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Pre-exposure antiretroviral prophylaxis (PrEP) attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience, but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50(1):77–83.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Voetsch AC, Heffelfinger JD, Begley EB, Jafa-Bhushan K, Sullivan PS. Knowledge and use of preexposure and postexposure prophylaxis among attendees of minority gay pride events, 2005 through 2006. J Acquir Immune Defic Syndr. 2007;46(3):378–80.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Buttram ME. The informal use of antiretroviral medications for HIV prevention by men who have sex with men in South Florida: initiation, use practices, medications and motivations. Cult, Health Sex. 2018.  https://doi.org/10.1080/13691058.2017.1421709.CrossRefGoogle Scholar
  21. 21.
    Kurtz SP, Buttram ME. Misunderstanding of pre-exposure prophylaxis use among MSM: public health and policy implications. LGBT Health. 2016;3(6):461–4.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Philpott S. Social justice, public health ethics, and the use of HIV pre-exposure prophylaxis. Am J Prev Med. 2013;44(IS2):S137–40.CrossRefPubMedGoogle Scholar
  23. 23.
    Koenig LJ, Lyles C, Smith DK. Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studies. Am J Prev Med. 2013;44(IS2):S91–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11(3):e1001613.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Dimitrov D, Boily M-C, Mȃsse BR, Brown ER. Impact of pill sharing on drug resistance due to a wide-scale oral PrEP intervention in generalized epidemics. J AIDS Clin Res. 2012; Supplement 5(4).Google Scholar
  26. 26.
    Kippax S. Effective HIV prevention: the indispensable role of social science. J Int AIDS Soc. 2012;15(2):17357.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Bernard RH. Research methods in anthropology: qualitative and quantitative approaches. New York: AltaMira Press; 2011.Google Scholar
  28. 28.
    Saldaña J. The coding manual for qualitative researchers. Los Angeles: Sage; 2013.Google Scholar
  29. 29.
    Barbour RS. Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ. 2001;322(7294):1115–7.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Centers for Disease Control and Prevention. HIV testing and risk behaviors among gay, bisexual, and other men who have sex with men—United States. Morb Mortal Wkly Rep. 2013;62(47):958–62.Google Scholar
  31. 31.
    Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2016. HIV Surveillance Report, volume 28. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2016-vol-28.pdf. Accessed 3 July 2018.
  32. 32.
    U.S. Census Bureau. Population without health insurance coverage: 25 most populous metro areas: 2013–2016. https://www.census.gov/content/dam/Census/library/visualizations/2017/demo/p60-260/Unins_25metroareas.pdf. Accessed 3 July 2018.
  33. 33.
    Surratt HL, Kurtz SP, Cicero TJ, O’Grady C, Levi-Minzi MA. Antiretroviral medication diversion among HIV-positive substance abusers in South Florida. Am J Public Health. 2013;103(6):1026–8.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Doblecki-Lewis S, Liu A, Feaster D, Cohen SE, Cardens G, Bacon O, et al. Healthcare access and PrEP continuation in San Francisco and Miami after US PrEP Demo Project. J Acquir Immune Defic Syndr. 2017;74(5):531–8.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Galea JT, Cook R, Pickett J, Gorbach PM. PrEP in the wild: results from a global survey of medical providers’ PrEP practices in settings where it is approved and where it is not. In: 9th International AIDS Society Conference on HIV Science; July 23–26; Paris, France 2017.Google Scholar
  36. 36.
    Galea J, Cook R, Pickett J, Gorbach PM. “PrEP in the wild”—preliminary results from a global survey on “informal” PrEP use in settings where it is approved and where it is not. HIV Research for Prevention; October 17–21; Chicago, IL 2016.Google Scholar
  37. 37.
    Buttram ME, Kurtz SP. Preliminary evidence of HIV seroconversion among HIV-negative men who have sex with men taking non-prescribed antiretrovirals for HIV prevention in Miami, Florida, USA. Sex Health. 2016;14(2):193–5.Google Scholar
  38. 38.
    Molina JM, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.CrossRefPubMedGoogle Scholar
  39. 39.
    Lykins WR, Luecke E, Johengen D, van der Straten A, Desai TA. Long acting systemic HIV pre-exposure prophylaxis: an examination of the field. Drug Deliv Transl Res. 2017;7(6):805–16.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Center for Applied Research on Substance Use and Health DisparitiesNova Southeastern UniversityMiamiUSA
  2. 2.Center for Applied Research on Substance Use and Health DisparitiesNova Southeastern UniversityMiamiUSA

Personalised recommendations